Artiva Biotherapeutics, Inc. (ARTV)

NGM – Real Time Price. Currency in USD

11.68

-0.10 (-0.89%)

Market open: Aug 12, 2026, 1:08 PM EDT

11.61

-0.17 (-1.44%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

251K

33M

Cost of goods sold

-3M

-2M

-1M

Gross Profit

-3M

-2M

31M

Operating expenses (excl. COGS)

-88M

-66M

-62M

-64M

Operating Income

-91M

-68M

-31M

-60M

Non-operating income, total

Pretax income

-84M

-65M

-29M

-59M

Equity in earnings

Taxes

-72K

-53K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-84M

-65M

-29M

-59M

Discontinued operations

Net income

-84M

-65M

-29M

-59M

Dilution adjustment

Preferred dividends

Artiva Biotherapeutics, Inc. (ARTV)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Artiva Biotherapeutics, Inc. (ARTV)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Artiva Biotherapeutics, Inc. (ARTV)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Artiva Biotherapeutics, Inc. (ARTV)

Income Statement (Annual)

Income Statement (Annual)